Skip to content

Safety testing of cosmetic product using Patch Test

Evaluation of dermatological safety and adverse reaction of Entice Glow Moisturizer for dermatological safety by 24 hrs patch test under complete occlusion on healthy human subjects..

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/07/035262
Enrollment
24
Registered
2021-07-29
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Entice Glow Moisturizer: Dose : 500mg Frequency: once daily Duration : 24 hrs The product is applied to the volunteer by patch using IQ chambers. Control Intervention1: NIL: NIL

Sponsors

Entice Supplements Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects in age group 18 - 55 years (both the ages inclusive). 2. Healthy male & female subjects. 3. Subjects with Fitzpatrick skin type III to V. 4. Subjects willing to give a written informed consent. 5. Subjects willing to maintain the patch test in position for 24 hours. 6. Subject having not participated in a similar investigation in the past one month. 7. Subjects willing to come for regular follow up visits. 8. Subjects ready to follow instructions during the study period. Test period: 9 days for all subjects including screening day.

Exclusion criteria

Exclusion criteria: 1. Infection, allergy on the tested area. 2. Skin allergy, antecedents or atopic subjects. 3. Athletes and subjects with history of excessive sweating. 4. Cutaneous disease which may influence the study result. 5. Subjects on oral corticosteroid . 6. Subjects participating in any other cosmetic or therapeutic study. 7. Any history of underlying uncontrolled medical illness including diabetes, liver disease or history of alcoholism, HIV or any other serious medical illness.

Design outcomes

Primary

MeasureTime frame
The objective of this study is to evaluate the dermatological safety of the given investigational product/s on skin of healthy human volunteers by dermatological visual assessmentTimepoint: 24 hrs

Secondary

MeasureTime frame
Adverse event monitoringTimepoint: 0 hr to 24 hrs

Countries

India

Contacts

Public ContactMsSushmithaS

Entice Supplements Pvt Ltd

sushmitha.gowda9425@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026